1999
DOI: 10.1093/clinchem/45.9.1681
|View full text |Cite
|
Sign up to set email alerts
|

Design of a Biosensor for Continual, Transdermal Glucose Monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0
1

Year Published

2000
2000
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(18 citation statements)
references
References 2 publications
0
17
0
1
Order By: Relevance
“…Although the glucose biosensor of the GlucoWatch has a linear (r 2 ~ 0.98) glucose response range of 0-28 mM which is larger than the one in this study (r 2 ~ 1.00, 0-4 mM), the amount of transdermal glucose extraction by reverse iontophoresis are several orders of magnitude lower than those present in the blood (~5 µM vs ~ 5 mM). 28 Therefore, our glucose biosensor can cover the concentrations of the transdermally extracted glucose and be useful in a clinical setting. Glucose concentration at diffusion cell (mM) Biosensor current response (µA) Figure 5 Evaluation of the biosensor for noninvasive glucose measurement by reverse iontophoresis.…”
Section: Hydrodynamic Voltammogram Of the Glucose Biosensormentioning
confidence: 99%
See 1 more Smart Citation
“…Although the glucose biosensor of the GlucoWatch has a linear (r 2 ~ 0.98) glucose response range of 0-28 mM which is larger than the one in this study (r 2 ~ 1.00, 0-4 mM), the amount of transdermal glucose extraction by reverse iontophoresis are several orders of magnitude lower than those present in the blood (~5 µM vs ~ 5 mM). 28 Therefore, our glucose biosensor can cover the concentrations of the transdermally extracted glucose and be useful in a clinical setting. Glucose concentration at diffusion cell (mM) Biosensor current response (µA) Figure 5 Evaluation of the biosensor for noninvasive glucose measurement by reverse iontophoresis.…”
Section: Hydrodynamic Voltammogram Of the Glucose Biosensormentioning
confidence: 99%
“…[10][11][12][13][14][15] The authors only found reports of a glucose sensor integrated with reverse iontophoresis function. 11,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] This glucose biosensor, approved by the US Food and Drug Administration, is GlucoWatch ® biographer, which passes a small current between two skin-surface hydrogel electrodes to extract glucose-containing interstitial fluid into hydrogel pads, incorporating a glucose oxidase (GOD) biosensor. 14,17,31 Unfortunately, GlucoWatch causes several problems, such as skin irritation or rash under the device in a number of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Although the glucose biosensor of the GlucoWatch has a linear (r 2 ~ 0.98) glucose response range of 0-28 mM which is larger than the one in this study (r 2 ~ 1.00, 0-4 mM), the amount of transdermal glucose extraction by reverse iontophoresis are several orders of magnitude lower than those present in the blood (~5 µM vs ~ 5 mM). 28 Therefore, our glucose biosensor can cover the concentrations of the transdermally extracted glucose and be useful in a clinical setting. Glucose concentration at diffusion cell (mM) Biosensor current response (µA) The use of the biosensor for noninvasive glucose measurement by reverse iontophoresis…”
Section: Hydrodynamic Voltammogram Of the Glucose Biosensormentioning
confidence: 99%
“…[10][11][12][13][14][15] The authors only found reports of a glucose sensor integrated with reverse iontophoresis function. 11,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] This glucose biosensor, approved by the US Food and Drug Administration, is GlucoWatch ® biographer, which passes a small International Journal of Nanomedicine downloaded from https://www.dovepress.com/ by 44.224.250.200 on For personal use only.…”
Section: Introductionmentioning
confidence: 99%
“…Conventional glucose-sensing methods can be broadly classified into point sample methods and the more recent continuous monitoring methods 5 . The point sample testing is an enzymatic method done by means of finger pricking and tests on urine samples, whereas the continuous monitoring methods may be invasive, minimally invasive or non-invasive depending upon the use of intravenous/subcutaneous sensor 6 , microneedles 7 , 8 or optical/transdermal sensors 9 , 10 , respectively. The proposed microwave-based measurement scheme is minimally invasive and provides ultrafast results and therefore is a good contender among continuous monitoring methods.…”
Section: Introductionmentioning
confidence: 99%